Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model.
Liljefors T, Bøgesø KP, Hyttel J, Wikström H, Svensson K, Carlsson A. Liljefors T, et al. J Med Chem. 1990 Mar;33(3):1015-22. doi: 10.1021/jm00165a020. J Med Chem. 1990. PMID: 1968512
Differentiation of classical and novel antipsychotics using animal models.
Arnt J, Skarsfeldt T, Hyttel J. Arnt J, et al. Among authors: hyttel j. Int Clin Psychopharmacol. 1997 Feb;12 Suppl 1:S9-17. doi: 10.1097/00004850-199702001-00003. Int Clin Psychopharmacol. 1997. PMID: 9179639 Review.
Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K, Liljefors T, Hyttel J, Perregaard J. Andersen K, et al. Among authors: hyttel j. J Med Chem. 1996 Sep 13;39(19):3723-38. doi: 10.1021/jm960159f. J Med Chem. 1996. PMID: 8809161
Interaction of the antiemetic metopimazine and anticancer agents with brain dopamine D2, 5-hydroxytryptamine3, histamine H1, muscarine cholinergic and alpha 1-adrenergic receptors.
Herrstedt J, Hyttel J, Pedersen J. Herrstedt J, et al. Among authors: hyttel j. Cancer Chemother Pharmacol. 1993;33(1):53-6. doi: 10.1007/BF00686023. Cancer Chemother Pharmacol. 1993. PMID: 8269589
98 results
Jump to page